Insiders Arrowhead Pharmaceuticals, Inc.

Equities

ARWR

US04280A1007

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
22.12 ^USD	+1.14%		-0.94%	-27.71%

Apr. 24	Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease	CI
Apr. 07	Arrowhead Pharmaceuticals, Inc. Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Arrowhead Pharmaceuticals, Inc. Appoints Hongbo Lu as Independent Director, Effective April 1, 2024	Feb. 22	CI
Arrowhead Pharmaceuticals Insider Sold Shares Worth $1,860,019, According to a Recent SEC Filing	Feb. 02	MT
Arrowhead Pharmaceuticals, Inc. Announces Leaving of Javier San Martin, M.D., as the Chief Medical Officer, Effective from February 1, 2024	Jan. 22	CI
Arrowhead Pharmaceuticals Insider Sold Shares Worth $292,804, According to a Recent SEC Filing	Jan. 08	MT
Arrowhead Pharmaceuticals Insider Sold Shares Worth $567,910, According to a Recent SEC Filing	Jan. 08	MT
Arrowhead Pharmaceuticals Insider Sold Shares Worth $342,480, According to a Recent SEC Filing	Dec. 22	MT
Arrowhead Pharmaceuticals Insider Sold Shares Worth $567,315, According to a Recent SEC Filing	Nov. 22	MT
Arrowhead Pharmaceuticals Insider Sold Shares Worth $589,223, According to a Recent SEC Filing	23-10-30	MT
Arrowhead Pharmaceuticals Insider Sold Shares Worth $1,624,223, According to a Recent SEC Filing	23-09-21	MT
Insider Sell: Arrowhead Pharmaceuticals	23-05-08	MT
Arrowhead Pharmaceuticals, Inc. Announces Resignation of Marianne De Backer, Director, Effective as of April 2, 2023	23-02-14	CI
Insider Sell: Arrowhead Pharmaceuticals	23-01-03	MT
Arrowhead Pharmaceuticals, Inc. Appoints Patrick O’Brien as Chief Operating Officer	22-07-20	CI
Arrowhead Pharmaceuticals, Inc. Appoints Victoria Vakiener to Board of Directors	22-05-02	CI
Insider Sell: Arrowhead Pharmaceuticals	22-02-14	MT
Insider Sell: Arrowhead Pharmaceuticals	22-01-10	MT
Insider Sell: Arrowhead Pharmaceuticals	22-01-07	MT
Insider Sell: Arrowhead Pharmaceuticals	22-01-07	MT
Insider Sell: Arrowhead Pharmaceuticals	21-12-20	MT
Insider Sell: Arrowhead Pharmaceuticals	21-11-22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Arrowhead Pharmaceuticals, Inc.

Equities

ARWR

US04280A1007

Insiders

Filters